Glenmark Life Sciences' Stock Reaches All-Time High, Rated 'Hold' by MarketsMOJO
Glenmark Life Sciences, a midcap pharmaceutical company, has reached an all-time high in the stock market with its share price increasing by 0.97%. Despite a recent trend reversal, the stock is still performing well and has outperformed the sector and Sensex. With a 'Hold' rating from MarketsMojo, the company shows potential for future growth.
Glenmark Life Sciences, a midcap pharmaceutical company, has been making headlines in the stock market as its share price reached an all-time high on September 10, 2024. The company's stock call has been rated as 'Hold' by MarketsMOJO, a leading financial research and advisory firm.
According to the price summary, Glenmark Life Sciences is currently trading at a price that is 0.97% away from its 52-week high of Rs 1219.7. However, the stock has underperformed the sector by -0.42% in today's trading session. This could be due to the stock's recent trend reversal, as it has fallen after four consecutive days of gains.
Despite this, Glenmark Life Sciences is still performing well in the market, with its stock trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.
In terms of overall performance, Glenmark Life Sciences has outperformed the Sensex, with a 1-year performance of 95.74% compared to the Sensex's 22.60%. This showcases the company's strong growth and potential in the pharmaceutical industry.
As a midcap company, Glenmark Life Sciences has been steadily gaining traction in the market and its recent all-time high is a testament to its success. With a 'Hold' rating from MarketsMOJO, investors can keep a close eye on this promising pharmaceutical company.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
